Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 155
Immune Disorders Drugs 73
Genomics 73
Biopharmaceuticals 73
Biotechnology 50
Pharmaceuticals 43
Musculoskeletal Disorders Drugs 42
Oncology Drugs 41
Drug Discovery 39
Hematological Drugs 36
Biosimilars and Biosuperiors 31
Alzheimer's Disease Drugs 27
Infusions and Injectables 25
Cardiovascular Drugs 24
Allergy and Immunology 22
Clinical Trials 22
Optical Disorders Drugs 21
Mental Disorders Drugs 19
Neurology 17
Needles and Syringes 17
E-Healthcare 14
Respiratory Drugs 14
Psoriasis Drugs 14
Infectious Diseases Drugs 12
Optical 12
Pharmaceutical Manufacturing 12
Immunosuppressive Drugs 12
Healthcare Services 11
Hematology 11
Gastrointestinal Drugs 11
Drug Delivery 10
Drugs by Therapeutic Area 9
Lymphoma Drugs 9
Diagnostics 9
Endocrine and Metabolic Disorders Drugs 9
Therapeutic Area 8
Leukemia Drugs 8
Analgesics 8
Pulmonary Medicine 7
Liver and Kidney Disorders Drugs 7
Enzymes 5
Medical Devices 5
Oncology 5
Schizophrenia Drugs 5
Company Reports 4
Proteomics 4
Mental Health 4
Neurology Devices 4
Cardiology 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Stem Cells 3
Hospital Management 3
Dermatology 3
Vitamins and Dietary Supplements 3
Gastroenterology 3
Dermatological Drugs 3
Urology and Nephrology 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Biomaterials 2
Biomarkers 2
Vaccines 2
Skin Cancer Drugs 2
Laboratory Equipment 2
Pediatrics 2
Anxiety Drugs 2
Addiction Disorders Drugs 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Lung Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Brain Cancer Drugs 1
Medical Imaging 1
Infectious Disease Testing 1
Transdermal and Transmucosal Drug Delivery 1
Contrast Media 1
Kidney Cancer Drugs 1
Nanomedicine 1
Antibiotics 1
Clinical Skills 1
Anatomy 1
Endocrinology 1
Allergy Drugs 1
Asthma Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

860 Results (Page 28 of 43)
- Relevance
  Sort by

Therapeutic Proteins Market Report 2025

 Report
April 2025
175 Pages
Global

From

€4006EUR$4,490USD£3,533GBP

Cancer biologics Market Report 2025

 Report
April 2025
250 Pages
Global

From

€4006EUR$4,490USD£3,533GBP

Biologics Market Report 2025

 Report
March 2025
400 Pages
Global

From

€4006EUR$4,490USD£3,533GBP

Addisons Disease Therapeutics Market 2024-2028

 Report
August 2024
166 Pages
Global

From

€2231EUR$2,500USD£1,967GBP

Advanced Therapy Medicinal Products Market Size, Share & Trends Analysis Report by Therapy Type (Cell Therapy, Gene Therapy, Tissue Engineered Product), Region (North America, Europe, APAC, ROW), and Segment Forecasts, 2023-2030

 Report
December 2023
120 Pages
Global

From

€5309EUR$5,950USD£4,681GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Next-Generation Antibody Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4006EUR$4,490USD£3,533GBP

Angelman Syndrome- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1071EUR$1,200USD£944GBP

€1338EUR$1,500USD£1,180GBP

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: An Industry Landscape Analysis of Stakeholders, Technologies, Pipeline, Partnering and Financing

 Report
March 2022
553 Pages
Global

From

€2450EUR$2,941USD£2,236GBP

Chronic Pain Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4006EUR$4,490USD£3,533GBP

Sciatic Pain - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1428EUR$1,600USD£1,259GBP

€1785EUR$2,000USD£1,574GBP

Digital Biomarkers Market - Global Forecast 2025-2032

 Report
October 2025
188 Pages
Global

From

€3163EUR$3,545USD£2,789GBP

€3515EUR$3,939USD£3,099GBP

Pharmaceutical Drugs Industry: Global Competitive Landscape 2021

 Report
October 2022
307 Pages
Global

From

€4908EUR$5,500USD£4,327GBP

Major Depressive Disorder - Eight-Market Drug Forecast and Market Analysis - Update

 Report
December 2023
117 Pages
Global

From

€13380EUR$14,995USD£11,798GBP

RNA Targeting Small Molecules Therapeutics Market by Type of Target Molecule, Type of Approach, Target Indication, Target Therapeutic Area, Route of Administration, and Key Geographical Region: Industry Trends and Global Forecasts, 2021-2030

 Report
August 2021
265 Pages
Global

From

€4282EUR$4,799USD£3,776GBP

Cerebral Infarction Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

 Report
April 2025
135 Pages
Global

From

€3678EUR$4,123USD£3,243GBP

€4328EUR$4,850USD£3,816GBP

Neurologic Disorders Therapeutics Market 2024-2028

 Report
July 2024
150 Pages
Global

From

€2231EUR$2,500USD£1,967GBP

Acute Ischemic Stroke Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4006EUR$4,490USD£3,533GBP

Injectable Drugs Market - Global Forecast 2025-2032

 Report
October 2025
184 Pages
Global

From

€3163EUR$3,545USD£2,789GBP

€3515EUR$3,939USD£3,099GBP

Atherosclerosis Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4006EUR$4,490USD£3,533GBP

Digital Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
August 2025
170 Pages
Global

From

€4015EUR$4,500USD£3,540GBP

860 Results (Page 28 of 43)
- 1
- 26
- 27
- 28
- 29
- 30

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.